SGS Adds In Vitro Toxicology Testing at Canadian LabAllbiopro2018-10-26T10:39:16+09:0010월 26th, 2018|
EU biosimilar embrace hits Roche’s Herceptin hard, but the pain is coming for AbbVie, J&J and more: reportAllbiopro2018-10-25T09:44:44+09:0010월 25th, 2018|
Chasing Johnson & Johnson and Pfizer, Bayer hits goal in prostate cancer phase 3Allbiopro2018-10-25T09:44:14+09:0010월 25th, 2018|
Pfizer/Lilly showcase data for NGF pain drug tanezumab at ACRAllbiopro2018-10-25T09:43:46+09:0010월 25th, 2018|
Ray Tabibiazar departs Aravive to head up development at Twist BioscienceAllbiopro2018-10-25T09:43:13+09:0010월 25th, 2018|
Single-use, double-digits: Robust quarters for Pall and SartoriusAllbiopro2018-10-25T09:42:45+09:0010월 25th, 2018|
Amgen Invests $66 Million In Oxford Nanopore TechnologiesAllbiopro2018-10-25T09:41:50+09:0010월 25th, 2018|
AstraZeneca Announces Expansion of Oncology Collaboration with Innate PharmaAllbiopro2018-10-25T09:40:56+09:0010월 25th, 2018|
AstraZeneca Announces Expansion of Oncology Collaboration with Innate PharmaAllbiopro2018-10-25T09:40:00+09:0010월 25th, 2018|
FDA Approves Lupin’s Generic Triamcinolone Acetonide Ointment USP, 0.1%Allbiopro2018-10-24T10:32:10+09:0010월 24th, 2018|
Updated: BioSpace’s List of Q4 2018 Life Sciences IPOsAllbiopro2018-10-24T10:31:40+09:0010월 24th, 2018|
Grace Under Fire: How to Respond to Tough Job Interview QuestionsAllbiopro2018-10-24T10:31:12+09:0010월 24th, 2018|
Celgene Brings in Merck KGaA Vet as Part of an Effort to Fix Clinical Development WoesAllbiopro2018-10-24T10:30:45+09:0010월 24th, 2018|
Healthy Lung Month: Emerging Treatment Options for Mesothelioma PatientsAllbiopro2018-10-24T10:30:18+09:0010월 24th, 2018|
Synthego Snags $110 Million in Series C to Advance Vision of Making CRISPR Technology More AvailableAllbiopro2018-10-24T10:29:50+09:0010월 24th, 2018|
